T. Rowe Price Associates
APVO icon

T. Rowe Price Associates’s Aptevo Therapeutics APVO Stock Holding History

T. Rowe Price Associates’s Portfolio APVO Stock Details APVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Hold
0
– -$16K – 2907
2023
Q3 		– Hold
0
– – – 2861
2023
Q2 		– Hold
0
– – – 2763
2023
Q1 		– Hold
0
– – – 2696
2022
Q4 		– Hold
0
– – – 2704
2022
Q3 		– Hold
0
– – – 2645
2022
Q2 		– Hold
0
– – – 2648
2022
Q1 		– Hold
0
– – – 2585
2021
Q4 		– Hold
0
– – – 2525
2021
Q1 		– Hold
0
– -$231K – 2845
2020
Q4 		– Hold
0
– – – 2520
2017
Q4 		– Hold
0
– -$47K – 2566
2017
Q3 		– Hold
0
– – – 2547
2017
Q2 		– Hold
0
– – – 2534
2017
Q1 		– Hold
0
– – – 2546
2016
Q4 		– Hold
0
– – – 2521
2016
Q3 		– Hold
0
– – – 2494

Other funds holding APVO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return